Avita Medical, Inc.

Good day, and thank you for standing by, and welcome to Aveda Medical Third Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during the session, you will need to press star 11 on your telephone. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Jim Corbett, CEO. Please go ahead.

Thank you, Operator.

Welcome to Aveda Medical's third quarter 2022 earnings call. Joining me on today's call are Jim Corbett, Chief Executive Officer, and Michael Holder, Chief Financial Officer. This call will include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements made on this call that do not relate to matters of historical fact should be considered forward-looking statements, including statements regarding the markets in which Aveda Medical operates, trends, demand, and expectations for its products and technology, its expected financial performance expenses and position on the market, and the impact of COVID-19 on its operations and its customers' operations. These statements are neither promises nor guarantees and involve known and unknown risks and uncertainties that could cause actual results, performance, or achievements to differ materially from any results, performance, or achievements expressed or implied by the forward-looking statements. Please review Avita Medical's most recent filings with the SEC. particularly the risk factors described in Aveda Medical's S3 and 10-K filings and in Aveda Medical's quarterly report on Form 10-Q for the third quarter ended September 30, 2022, for additional information. Any forward-looking statements provided during this call, including projections for future performance, are based on management's expectations as of today. Aveda Medical undertakes no obligation to update these statements, except as required by applicable law. Avita Medical's press release, the third quarter 2022 results, is available on its website, www.avitamedical.com, under the Investors section, and includes additional details about its financial results. Avita Medical's website also has the latest SEC filings, which you are encouraged to review. A recording of today's call will be available on Avita Medical's website by 5 p.m. Pacific time today. Now, it's my pleasure to introduce you to Jim Corbett. Jim is a five-time life sciences CEO with over 30 years of experience leading global commercial stage companies. His deep expertise spans across many medical specialties and technologies with vast technical experience in the medical device industry. Additionally, Jim brings extensive experience across the capital markets, having served in both public and private companies. With that, I would like to turn the call over to Jim for his comments on third quarter 2022 business highlights.